The National Medical Products Administration approves the listing of Momisite tablets-瞭望新时代网-瞭望时代，放眼世界

The National Medical Products Administration approves the listing of Momisite tablets

2025-10-13

According to the website of the National Medical Products Administration, recently, the National Medical Products Administration approved the listing of the Class 1 innovative drug Momisist tablets submitted by Ganzhou Hemei Pharmaceutical Co., Ltd. through the priority review and approval process. The drug is suitable for treating adult patients with moderate to severe plaque psoriasis who meet the indications for phototherapy or systemic therapy. The drug's launch provides patients with new treatment options. (New Society)

Edit：Wang Shu Ying Responsible editor：Li Jie

Source：people.cn

Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email：lwxsd@liaowanghn.com

Return to home page Return to list